CRF1 RECEPTOR ANTAGONIST FOR THE TREATMENT OF CONGENITAL ADRENAL HYPERPLASIA

Provided are methods related to treating congenital adrenal hyperplasia in a subject in need thereof comprising administering to the subject a compound of Formula (I): [INSERT FORMULA] (I), or a pharmaceutically acceptable salt thereof. Se proporcionan métodos relacionados con el tratamiento de la h...

Full description

Saved in:
Bibliographic Details
Main Authors PARKS, Stacy, NGWENYA-JONES, Ayanda, CHARLIER, Anne, ZHANG, Xiaoping, MEHTON, Gurvinder, SAYERS, Brian, LOEWEN, Gordon RAPHAEL, IYOHA, Kingsley, VICKERY, Anthony D, CHAN, Jean L, ROBERTS, Eiry, CUTLER, JR., Gordon B, TAYLOR, Graeme, DOWNING, Kristie M, STIRN, Scott, GIRI, Nagdeep, FARBER, Robert H, COSTA, Christina MARIE, NAKANISHI, Arline
Format Patent
LanguageEnglish
Spanish
Published 06.07.2023
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Provided are methods related to treating congenital adrenal hyperplasia in a subject in need thereof comprising administering to the subject a compound of Formula (I): [INSERT FORMULA] (I), or a pharmaceutically acceptable salt thereof. Se proporcionan métodos relacionados con el tratamiento de la hiperplasia suprarrenal congénita en un sujeto que lo necesite que comprenden la administración al sujeto de un compuesto de Fórmula (I): i), o una sal farmacéuticamente aceptable del mismo.
Bibliography:Application Number: CR20220000624